Panbela Therapeutics Inc
Biotechnology
Healthcare
PBLA
24.40 K shares
NASDAQ US
traded
19 Dec 2023
listed
no
open
1.80
52 week high
7.13
high
1.90
52 week low
1.32
previous Close
1.32
P/E ratio
-0
market cap
4.24 M
div yield
0
net incoming
-5.83 M
-859.38 %
net profit margin
-583300000.00 %
0.00 %
operating incoming
-5.88 M
-12.69 %
net change in cash
1.97 M
-50.13 %
cash on hand
7.21 M
37.63 %
cost of revenue
5.88 M
20.93 %
top